{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:42:18Z","timestamp":1787499738183,"version":"build-2736575974"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12223-025-01315-y","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:34:30Z","timestamp":1755552870000},"page":"779-795","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunological orchestration and dysregulation in COVID-19 pneumonia: from viral pathogenesis to precision therapeutics in the post-pandemic era"],"prefix":"10.1007","volume":"70","author":[{"given":"Yun","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2065-2220","authenticated-orcid":false,"given":"Zhuying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"1315_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3379","volume":"370","author":"A Agarwal","year":"2020","unstructured":"Agarwal A, Hunt B, Stegemann M, Rochwerg B, Lamontagne F, Siemieniuk RA, Agoritsas T, Askie L, Lytvyn L, Leo YS, Macdonald H, Zeng L, Alhadyan A, Muna A, Amin W, da Silva ARA, Aryal D, Barragan FAJ, Bausch FJ, Burhan E, Calfee CS, Cecconi M, Chacko B, Chanda D, Dat VQ, De Sutter A, Du B, Freedman S, Geduld H, Gee P, Haider M, Gotte M, Harley N, Hashimi M, Hui D, Ismail M, Jehan F, Kabra SK, Kanda S, Kim YJ, Kissoon N, Krishna S, Kuppalli K, Kwizera A, Lado Castro-Rial M, Lisboa T, Lodha R, Mahaka I, Manai H, Mendelson M, Migliori GB, Mino G, Nsutebu E, Peter J, Preller J, Pshenichnaya N, Qadir N, Ranganathan SS, Relan P, Rylance J, Sabzwari S, Sarin R, Shankar-Hari M, Sharland M, Shen Y, Souza JP, Swanstrom R, Tshokey T, Ugarte S, Uyeki T, Evangelina VC, Venkatapuram S, Vuyiseka D, Wijewickrama A, Tran L, Zeraatkar D, Bartoszko JJ, Ge L, Brignardello-Petersen R, Owen A, Guyatt G, Diaz J, Kawano-Dourado L, Jacobs M, Vandvik PO (2020) A living WHO guideline on drugs for covid-19. BMJ 370. https:\/\/doi.org\/10.1136\/bmj.m3379","journal-title":"BMJ"},{"key":"1315_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120063","volume":"286","author":"S Ahmad","year":"2021","unstructured":"Ahmad S, Hatmal MM, Lambuk L, Al-Hatamleh MAI, Alshaer W, Mohamud R (2021) The role of TNFR2(+) Tregs in COVID-19: an overview and a potential therapeutic strategy. Life Sci 286. https:\/\/doi.org\/10.1016\/j.lfs.2021.120063","journal-title":"Life Sci"},{"key":"1315_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1052374","volume":"13","author":"M Akhtar","year":"2022","unstructured":"Akhtar M, Basher SR, Nizam NN, Kamruzzaman M, Khaton F, Banna HA, Kaisar MH, Karmakar PC, Hakim A, Akter A, Ahmed T, Tauheed I, Islam S, Ahmmed F, Mahamud S, Hasnat MA, Sumon MA, Rashed A, Ghosh S, Calderwood SB, Harris JB, Charles RC, LaRocque RC, Ryan ET, Banu S, Shirin T, Chowdhury F, Bhuiyan TR, Qadri F (2022) Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.1052374","journal-title":"Front Immunol"},{"key":"1315_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28403","volume":"95","author":"S Akrami","year":"2023","unstructured":"Akrami S, Montazeri EA, Saki M, Neisi N, Khedri R, Dini SA, Motlagh AA, Ahmadi F (2023) Bacterial profiles and their antibiotic resistance background in superinfections caused by multidrug-resistant bacteria among COVID-19 ICU patients from southwest Iran. J Med Virol 95. https:\/\/doi.org\/10.1002\/jmv.28403","journal-title":"J Med Virol"},{"key":"1315_CR5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01063-2021","author":"ZJ Andersen","year":"2021","unstructured":"Andersen ZJ, Hoffmann B, Morawska L, Adams M, Furman E, Yorgancioglu A, Greenbaum D, Neira M, Brunekreef B, Forastiere F, Rice MB, Wakenhut F, Coleen E, Boogaard H, Gehring U, Melen E, Ward B, De Matteis S (2021) Air pollution and COVID-19: clearing the air and charting a post-pandemic course: a joint workshop report of ERS, ISEE, HEI and WHO. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.01063-2021","journal-title":"Eur Respir J"},{"key":"1315_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n436","volume":"372","author":"AH Attaway","year":"2021","unstructured":"Attaway AH, Scheraga RG, Bhimraj A, Biehl M, Hatipoglu U (2021) Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ 372. https:\/\/doi.org\/10.1136\/bmj.n436","journal-title":"BMJ"},{"key":"1315_CR7","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s10875-020-00949-6","volume":"41","author":"V Azmy","year":"2021","unstructured":"Azmy V, Kaman K, Tang D, Zhao H, Dela Cruz C, Topal JE, Malinis M, Price CC (2021) Cytokine profiles before and after immune modulation in hospitalized patients with COVID-19. J Clin Immunol 41:738\u2013747. https:\/\/doi.org\/10.1007\/s10875-020-00949-6","journal-title":"J Clin Immunol"},{"issue":"243\u2013259","key":"1315_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2022.12.005","volume":"31","author":"KC Barnett","year":"2023","unstructured":"Barnett KC, Xie Y, Asakura T, Song D, Liang K, Taft-Benz SA, Guo H, Yang S, Okuda K, Gilmore RC, Loome JF, Oguin Iii TH, Sempowski GD, Randell SH, Heise MT, Lei YL, Boucher RC, Ting JP (2023) An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2. Cell Host Microbe 31(243\u2013259). https:\/\/doi.org\/10.1016\/j.chom.2022.12.005","journal-title":"Cell Host Microbe"},{"key":"1315_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.106239","volume":"176","author":"SS Batah","year":"2021","unstructured":"Batah SS, Fabro AT (2021) Pulmonary pathology of ARDS in COVID-19: a pathological review for clinicians. Respir Med 176. https:\/\/doi.org\/10.1016\/j.rmed.2020.106239","journal-title":"Respir Med"},{"key":"1315_CR10","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1126\/science.abk0414","volume":"374","author":"SPC Brand","year":"2021","unstructured":"Brand SPC, Ojal J, Aziza R, Were V, Okiro EA, Kombe IK, Mburu C, Ogero M, Agweyu A, Warimwe GM, Nyagwange J, Karanja H, Gitonga JN, Mugo D, Uyoga S, Adetifa IMO, Scott JAG, Otieno E, Murunga N, Otiende M, Ochola-Oyier LI, Agoti CN, Githinji G, Kasera K, Amoth P, Mwangangi M, Aman R, Ng\u2019ang\u2019a W, Tsofa B, Bejon P, Keeling MJ, Nokes DJ, Barasa E (2021) COVID-19 transmission dynamics underlying epidemic waves in Kenya. Science 374:989\u2013994. https:\/\/doi.org\/10.1126\/science.abk0414","journal-title":"Science"},{"key":"1315_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41579-022-00841-7","volume":"21","author":"AM Carabelli","year":"2023","unstructured":"Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, de Silva TI, Peacock SJ, Barclay WS, de Silva TI, Towers GJ, Robertson DL, Consortium C-GU (2023) SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol 21:162\u2013177. https:\/\/doi.org\/10.1038\/s41579-022-00841-7","journal-title":"Nat Rev Microbiol"},{"key":"1315_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/joim.13372","volume":"291","author":"X Castro Dopico","year":"2022","unstructured":"Castro Dopico X, Ols S, Lore K, Karlsson Hedestam GB (2022) Immunity to SARS-CoV-2 induced by infection or vaccination. J Intern Med 291:32\u201350. https:\/\/doi.org\/10.1111\/joim.13372","journal-title":"J Intern Med"},{"key":"1315_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/JLB.5COVCRA0721-387RR","volume":"112","author":"R Cervantes-Diaz","year":"2022","unstructured":"Cervantes-Diaz R, Sosa-Hernandez VA, Romero-Ramirez S, Torres-Ruiz J, Perez-Fragoso A, Meza-Sanchez DE, Gomez-Martin D, Maravillas-Montero JL (2022) Circulating B10 regulatory cells are decreased in severe and critical COVID-19. J Leukoc Biol 112:333\u2013337. https:\/\/doi.org\/10.1002\/JLB.5COVCRA0721-387RR","journal-title":"J Leukoc Biol"},{"issue":"1496\u20131507","key":"1315_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.10.051","volume":"183","author":"Y Chen","year":"2020","unstructured":"Chen Y, Zuiani A, Fischinger S, Mullur J, Atyeo C, Travers M, Lelis FJN, Pullen KM, Martin H, Tong P, Gautam A, Habibi S, Bensko J, Gakpo D, Feldman J, Hauser BM, Caradonna TM, Cai Y, Burke JS, Lin J, Lederer JA, Lam EC, Lavine CL, Seaman MS, Chen B, Schmidt AG, Balazs AB, Lauffenburger DA, Alter G, Wesemann DR (2020) Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production. Cell 183(1496\u20131507). https:\/\/doi.org\/10.1016\/j.cell.2020.10.051","journal-title":"Cell"},{"key":"1315_CR15","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130:2620\u20132629. https:\/\/doi.org\/10.1172\/JCI137244","journal-title":"J Clin Invest"},{"key":"1315_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/v13020182","author":"C Chiang","year":"2021","unstructured":"Chiang C, Liu G, Gack MU (2021) Viral evasion of RIG-I-like receptor-mediated immunity through dysregulation of ubiquitination and ISGylation. Viruses. https:\/\/doi.org\/10.3390\/v13020182","journal-title":"Viruses"},{"key":"1315_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","volume":"53","author":"F Coperchini","year":"2020","unstructured":"Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M (2020) The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system. Cytokine Growth Factor Rev 53:25\u201332. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.05.003","journal-title":"Cytokine Growth Factor Rev"},{"key":"1315_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155971","volume":"157","author":"BG Csordas","year":"2022","unstructured":"Csordas BG, de Sousa Palmeira PH, Peixoto RF, Comberlang F, de Medeiros IA, Azevedo F, Veras RC, Janebro DI, Amaral IPG, Barbosa-Filho JM, Keesen TSL (2022) Is IFN expression by NK cells a hallmark of severe COVID-19? Cytokine 157. https:\/\/doi.org\/10.1016\/j.cyto.2022.155971","journal-title":"Cytokine"},{"issue":"860\u2013871","key":"1315_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.01.019","volume":"185","author":"Z Cui","year":"2022","unstructured":"Cui Z, Liu P, Wang N, Wang L, Fan K, Zhu Q, Wang K, Chen R, Feng R, Jia Z, Yang M, Xu G, Zhu B, Fu W, Chu T, Feng L, Wang Y, Pei X, Yang P, Xie XS, Cao L, Cao Y, Wang X (2022) Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron. Cell 185(860\u2013871). https:\/\/doi.org\/10.1016\/j.cell.2022.01.019","journal-title":"Cell"},{"key":"1315_CR20","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(21)00624-3","volume":"397","author":"RS D\u2019Souza","year":"2021","unstructured":"D\u2019Souza RS, Wolfe I (2021) COVID-19 vaccines in high-risk ethnic groups. Lancet 397:1348. https:\/\/doi.org\/10.1016\/S0140-6736(21)00624-3","journal-title":"Lancet"},{"key":"1315_CR21","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.00375.2021","volume":"322","author":"AD Desai","year":"2022","unstructured":"Desai AD, Lavelle M, Boursiquot BC, Wan EY (2022) Long-term complications of COVID-19. Am J Physiol Cell Physiol 322:C1\u2013C11. https:\/\/doi.org\/10.1152\/ajpcell.00375.2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"1315_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030699","author":"M Dhawan","year":"2023","unstructured":"Dhawan M, Rabaan AA, Alwarthan S, Alhajri M, Halwani MA, Alshengeti A, Najim MA, Alwashmi ASS, Alshehri AA, Alshamrani SA, AlShehail BM, Garout M, Al-Abdulhadi S, Al-Ahmed SH, Thakur N, Verma G (2023) Regulatory t cells (Tregs) and COVID-19: unveiling the mechanisms, and therapeutic potentialities with a special focus on long COVID. Vaccines. https:\/\/doi.org\/10.3390\/vaccines11030699","journal-title":"Vaccines"},{"key":"1315_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1109\/RBME.2020.2990959","volume":"14","author":"D Dong","year":"2021","unstructured":"Dong D, Tang Z, Wang S, Hui H, Gong L, Lu Y, Xue Z, Liao H, Chen F, Yang F, Jin R, Wang K, Liu Z, Wei J, Mu W, Zhang H, Jiang J, Tian J, Li H (2021) The role of imaging in the detection and management of COVID-19: a review. IEEE Rev Biomed Eng 14:16\u201329. https:\/\/doi.org\/10.1109\/RBME.2020.2990959","journal-title":"IEEE Rev Biomed Eng"},{"key":"1315_CR24","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1056\/NEJMoa2102685","volume":"385","author":"M Dougan","year":"2021","unstructured":"Dougan M, Nirula A, Azizad M, Mocherla B, Gottlieb RL, Chen P, Hebert C, Perry R, Boscia J, Heller B, Morris J, Crystal C, Igbinadolor A, Huhn G, Cardona J, Shawa I, Kumar P, Adams AC, Van Naarden J, Custer KL, Durante M, Oakley G, Schade AE, Holzer TR, Ebert PJ, Higgs RE, Kallewaard NL, Sabo J, Patel DR, Dabora MC, Klekotka P, Shen L, Skovronsky DM, Investigators B- (2021) Bamlanivimab plus etesevimab in mild or moderate Covid-19. N Engl J Med 385:1382\u20131392. https:\/\/doi.org\/10.1056\/NEJMoa2102685","journal-title":"N Engl J Med"},{"key":"1315_CR25","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1002\/jmv.27757","volume":"94","author":"B Elie","year":"2022","unstructured":"Elie B, Roquebert B, Sofonea MT, Trombert-Paolantoni S, Foulongne V, Guedj J, Haim-Boukobza S, Alizon S (2022) Variant-specific SARS-CoV-2 within-host kinetics. J Med Virol 94:3625\u20133633. https:\/\/doi.org\/10.1002\/jmv.27757","journal-title":"J Med Virol"},{"key":"1315_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.711616","volume":"9","author":"IH Elrobaa","year":"2021","unstructured":"Elrobaa IH, New KJ (2021) COVID-19: Pulmonary and extra pulmonary manifestations. Front Public Health 9. https:\/\/doi.org\/10.3389\/fpubh.2021.711616","journal-title":"Front Public Health"},{"key":"1315_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888897","volume":"13","author":"M Eskandarian Boroujeni","year":"2022","unstructured":"Eskandarian Boroujeni M, Sekrecka A, Antonczyk A, Hassani S, Sekrecki M, Nowicka H, Lopacinska N, Olya A, Kluzek K, Wesoly J, Bluyssen HAR (2022) Dysregulated interferon response and immune hyperactivation in severe COVID-19: targeting STATs as a novel therapeutic strategy. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.888897","journal-title":"Front Immunol"},{"key":"1315_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s12223-025-01256-6","author":"R Fan","year":"2025","unstructured":"Fan R, Liang Q, Sui Y, Yang Y, Yuan X (2025) The next viral pandemic-where do we stand? Folia Microbiol (Praha). https:\/\/doi.org\/10.1007\/s12223-025-01256-6","journal-title":"Folia Microbiol (Praha)"},{"key":"1315_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.654165","volume":"12","author":"J Fergie","year":"2021","unstructured":"Fergie J, Srivastava A (2021) Immunity to SARS-CoV-2: lessons learned. Front Immunol 12. https:\/\/doi.org\/10.3389\/fimmu.2021.654165","journal-title":"Front Immunol"},{"key":"1315_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/v14122629","author":"C Fernandez-de-Las-Penas","year":"2022","unstructured":"Fernandez-de-Las-Penas C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, Arendt-Nielsen L, Torres-Macho J, Plaza-Manzano G (2022) Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. https:\/\/doi.org\/10.3390\/v14122629","journal-title":"Viruses"},{"key":"1315_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1610","volume":"369","author":"RE Ferner","year":"2020","unstructured":"Ferner RE, Aronson JK (2020) Remdesivir in covid-19. BMJ 369. https:\/\/doi.org\/10.1136\/bmj.m1610","journal-title":"BMJ"},{"key":"1315_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1053\/j.semnuclmed.2021.07.001","volume":"52","author":"LS Freudenberg","year":"2022","unstructured":"Freudenberg LS, Pomykala KL, Herrmann K (2022) COVID-19 pandemic: what have we learned and what to expect in the future? Semin Nucl Med 52:86\u201389. https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.07.001","journal-title":"Semin Nucl Med"},{"key":"1315_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2116846","volume":"386","author":"RL Gottlieb","year":"2022","unstructured":"Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, Oguchi G, Ryan P, Nielsen BU, Brown M, Hidalgo A, Sachdeva Y, Mittal S, Osiyemi O, Skarbinski J, Juneja K, Hyland RH, Osinusi A, Chen S, Camus G, Abdelghany M, Davies S, Behenna-Renton N, Duff F, Marty FM, Katz MJ, Ginde AA, Brown SM, Schiffer JT, Hill JA, Investigators G-U- (2022) Early remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med 386:305\u2013315. https:\/\/doi.org\/10.1056\/NEJMoa2116846","journal-title":"N Engl J Med"},{"key":"1315_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.2021.11330","volume":"326","author":"M Shankar-Hari","year":"2021","unstructured":"Group WHOREAfC-TW, Shankar-Hari M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, Spiga F, Savovic J, Tierney J, Baron G, Benbenishty JS, Berry LR, Broman N, Cavalcanti AB, Colman R, De Buyser SL, Derde LPG, Domingo P, Omar SF, Fernandez-Cruz A, Feuth T, Garcia F, Garcia-Vicuna R, Gonzalez-Alvaro I, Gordon AC, Haynes R, Hermine O, Horby PW, Horick NK, Kumar K, Lambrecht BN, Landray MJ, Leal L, Lederer DJ, Lorenzi E, Mariette X, Merchante N, Misnan NA, Mohan SV, Nivens MC, Oksi J, Perez-Molina JA, Pizov R, Porcher R, Postma S, Rajasuriar R, Ramanan AV, Ravaud P, Reid PD, Rutgers A, Sancho-Lopez A, Seto TB, Sivapalasingam S, Soin AS, Staplin N, Stone JH, Strohbehn GW, Sunden-Cullberg J, Torre-Cisneros J, Tsai LW, van Hoogstraten H, van Meerten T, Veiga VC, Westerweel PE, Murthy S, Diaz JV, Marshall JC, Sterne JAC (2021) Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis. JAMA 326:499\u2013518. https:\/\/doi.org\/10.1001\/jama.2021.11330","journal-title":"JAMA"},{"key":"1315_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014962.pub2","author":"F Grundeis","year":"2023","unstructured":"Grundeis F, Ansems K, Dahms K, Thieme V, Metzendorf MI, Skoetz N, Benstoem C, Mikolajewska A, Griesel M, Fichtner F, Stegemann M (2023) Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD014962.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1315_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamainternmed.2020.6252","volume":"181","author":"S Gupta","year":"2021","unstructured":"Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, Reiser J, Bansal A, Srivastava A, Zhou Y, Finkel D, Green A, Mallappallil M, Faugno AJ, Zhang J, Velez JCQ, Shaefi S, Parikh CR, Charytan DM, Athavale AM, Friedman AN, Redfern RE, Short SAP, Correa S, Pokharel KK, Admon AJ, Donnelly JP, Gershengorn HB, Douin DJ, Semler MW, Hernan MA, Leaf DE, Investigators S-C (2021) Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern Med 181:41\u201351. https:\/\/doi.org\/10.1001\/jamainternmed.2020.6252","journal-title":"JAMA Intern Med"},{"key":"1315_CR37","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.1002\/jmv.27068","volume":"93","author":"B Gursoy","year":"2021","unstructured":"Gursoy B, Surmeli CD, Alkan M, Satici C, Altunok ES, Kamat S, Demirok B, Demirkol MA, Boru A (2021) Cytokine storm in severe COVID-19 pneumonia. J Med Virol 93:5474\u20135480. https:\/\/doi.org\/10.1002\/jmv.27068","journal-title":"J Med Virol"},{"key":"1315_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2313","volume":"32","author":"I Hadj Hassine","year":"2022","unstructured":"Hadj Hassine I (2022) Covid-19 vaccines and variants of concern: a review. Rev Med Virol 32. https:\/\/doi.org\/10.1002\/rmv.2313","journal-title":"Rev Med Virol"},{"key":"1315_CR39","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Pere H, Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, Carlier N, Gauzit R, Morbieu C, Pene F, Marin N, Roche N, Szwebel TA, Merkling SH, Treluyer JM, Veyer D, Mouthon L, Blanc C, Tharaux PL, Rozenberg F, Fischer A, Duffy D, Rieux-Laucat F, Kerneis S, Terrier B (2020) Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369:718\u2013724. https:\/\/doi.org\/10.1126\/science.abc6027","journal-title":"Science"},{"key":"1315_CR40","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.1002\/jmv.27965","volume":"94","author":"L Han","year":"2022","unstructured":"Han L, Zheng Y, Deng J, Nan ML, Xiao Y, Zhuang MW, Zhang J, Wang W, Gao C, Wang PH (2022) SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy. J Med Virol 94:5174\u20135188. https:\/\/doi.org\/10.1002\/jmv.27965","journal-title":"J Med Virol"},{"key":"1315_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","volume":"19","author":"Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, Ludden C, Reeve R, Rambaut A, Consortium C-GU, Peacock SJ, Robertson DL","year":"2021","unstructured":"Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, Ludden C, Reeve R, Rambaut A, Consortium C-GU, Peacock SJ, Robertson DL (2021) SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol 19:409\u2013424. https:\/\/doi.org\/10.1038\/s41579-021-00573-0","journal-title":"Nat Rev Microbiol"},{"key":"1315_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109634","volume":"252","author":"AD Hoffmann","year":"2023","unstructured":"Hoffmann AD, Weinberg SE, Swaminathan S, Chaudhuri S, Almubarak HF, Schipma MJ, Mao C, Wang X, El-Shennawy L, Dashzeveg NK, Wei J, Mehl PJ, Shihadah LJ, Wai CM, Ostiguin C, Jia Y, D\u2019Amico P, Wang NR, Luo Y, Demonbreun AR, Ison MG, Liu H, Fang D (2023) Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients. Clin Immunol 252. https:\/\/doi.org\/10.1016\/j.clim.2023.109634","journal-title":"Clin Immunol"},{"key":"1315_CR43","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12916-020-01673-z","volume":"18","author":"Y Hou","year":"2020","unstructured":"Hou Y, Zhao J, Martin W, Kallianpur A, Chung MK, Jehi L, Sharifi N, Erzurum S, Eng C, Cheng F (2020) New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Med 18:216. https:\/\/doi.org\/10.1186\/s12916-020-01673-z","journal-title":"BMC Med"},{"key":"1315_CR44","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00011-020-01401-6","volume":"69","author":"T Iba","year":"2020","unstructured":"Iba T, Connors JM, Levy JH (2020) The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res 69:1181\u20131189. https:\/\/doi.org\/10.1007\/s00011-020-01401-6","journal-title":"Inflamm Res"},{"key":"1315_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.560616","volume":"10","author":"KU Islam","year":"2020","unstructured":"Islam KU, Iqbal J (2020) An update on molecular diagnostics for COVID-19. Front Cell Infect Microbiol 10. https:\/\/doi.org\/10.3389\/fcimb.2020.560616","journal-title":"Front Cell Infect Microbiol"},{"key":"1315_CR46","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/jmv.27515","volume":"94","author":"M Kandeel","year":"2022","unstructured":"Kandeel M, Mohamed MEM, Abd El-Lateef HM, Venugopala KN, El-Beltagi HS (2022) Omicron variant genome evolution and phylogenetics. J Med Virol 94:1627\u20131632. https:\/\/doi.org\/10.1002\/jmv.27515","journal-title":"J Med Virol"},{"key":"1315_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13646","volume":"21","author":"R Kandhaya-Pillai","year":"2022","unstructured":"Kandhaya-Pillai R, Yang X, Tchkonia T, Martin GM, Kirkland JL, Oshima J (2022) TNF-alpha\/IFN-gamma synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK\/STAT1. Aging Cell 21. https:\/\/doi.org\/10.1111\/acel.13646","journal-title":"Aging Cell"},{"issue":"143\u2013157","key":"1315_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.025","volume":"183","author":"Kaneko N, Kuo HH, Boucau J, Farmer JR, Allard-Chamard H, Mahajan VS, Piechocka-Trocha A, Lefteri K, Osborn M, Bals J, Bartsch YC, Bonheur N, Caradonna TM, Chevalier J, Chowdhury F, Diefenbach TJ, Einkauf K, Fallon J, Feldman J, Finn KK, Garcia-Broncano P, Hartana CA, Hauser BM, Jiang C, Kaplonek P, Karpell M, Koscher EC, Lian X, Liu H, Liu J, Ly NL, Michell AR, Rassadkina Y, Seiger K, Sessa L, Shin S, Singh N, Sun W, Sun X, Ticheli HJ, Waring MT, Zhu AL, Alter G, Li JZ, Lingwood D, Schmidt AG, Lichterfeld M, Walker BD, Yu XG, Padera RF, Jr., Pillai S, Massachusetts Consortium on Pathogen Readiness Specimen Working G","year":"2020","unstructured":"Kaneko N, Kuo HH, Boucau J, Farmer JR, Allard-Chamard H, Mahajan VS, Piechocka-Trocha A, Lefteri K, Osborn M, Bals J, Bartsch YC, Bonheur N, Caradonna TM, Chevalier J, Chowdhury F, Diefenbach TJ, Einkauf K, Fallon J, Feldman J, Finn KK, Garcia-Broncano P, Hartana CA, Hauser BM, Jiang C, Kaplonek P, Karpell M, Koscher EC, Lian X, Liu H, Liu J, Ly NL, Michell AR, Rassadkina Y, Seiger K, Sessa L, Shin S, Singh N, Sun W, Sun X, Ticheli HJ, Waring MT, Zhu AL, Alter G, Li JZ, Lingwood D, Schmidt AG, Lichterfeld M, Walker BD, Yu XG, Padera RF, Jr., Pillai S, Massachusetts Consortium on Pathogen Readiness Specimen Working G (2020) Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19. Cell 183(143\u2013157). https:\/\/doi.org\/10.1016\/j.cell.2020.08.025","journal-title":"Cell"},{"key":"1315_CR49","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12967-022-03767-z","volume":"20","author":"R Karki","year":"2022","unstructured":"Karki R, Kanneganti TD (2022) Innate immunity, cytokine storm, and inflammatory cell death in COVID-19. J Transl Med 20:542. https:\/\/doi.org\/10.1186\/s12967-022-03767-z","journal-title":"J Transl Med"},{"key":"1315_CR50","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/14737159.2022.2122711","volume":"22","author":"A Kaushik","year":"2022","unstructured":"Kaushik A, Gupta S, Sood M, Steussy BW, Noll BW (2022) Smart and connected devices in point-of-care molecular diagnostics: what role can they play in the response to COVID-19? Expert Rev Mol Diagn 22:775\u2013781. https:\/\/doi.org\/10.1080\/14737159.2022.2122711","journal-title":"Expert Rev Mol Diagn"},{"key":"1315_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23115966","author":"R Kircheis","year":"2022","unstructured":"Kircheis R, Planz O (2022) Could a lower Toll-like receptor (TLR) and NF-\u03baB activation due to a changed charge distribution in the spike protein be the reason for the lower pathogenicity of Omicron? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23115966","journal-title":"Int J Mol Sci"},{"key":"1315_CR52","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.mayocp.2021.02.008","volume":"96","author":"SA Klassen","year":"2021","unstructured":"Klassen SA, Senefeld JW, Johnson PW, Carter RE, Wiggins CC, Shoham S, Grossman BJ, Henderson JP, Musser J, Salazar E, Hartman WR, Bouvier NM, Liu STH, Pirofski LA, Baker SE, van Helmond N, Wright RS, Fairweather D, Bruno KA, Wang Z, Paneth NS, Casadevall A, Joyner MJ (2021) The effect of convalescent plasma therapy on mortality among patients with COVID-19: systematic review and meta-analysis. Mayo Clin Proc 96:1262\u20131275. https:\/\/doi.org\/10.1016\/j.mayocp.2021.02.008","journal-title":"Mayo Clin Proc"},{"issue":"2650\u20132669","key":"1315_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.09.002","volume":"54","author":"B Kramer","year":"2021","unstructured":"Kramer B, Knoll R, Bonaguro L, ToVinh M, Raabe J, Astaburuaga-Garcia R, Schulte-Schrepping J, Kaiser KM, Rieke GJ, Bischoff J, Monin MB, Hoffmeister C, Schlabe S, De Domenico E, Reusch N, Handler K, Reynolds G, Bluthgen N, Hack G, Finnemann C, Nischalke HD, Strassburg CP, Stephenson E, Su Y, Gardner L, Yuan D, Chen D, Goldman J, Rosenstiel P, Schmidt SV, Latz E, Hrusovsky K, Ball AJ, Johnson JM, Koenig PA, Schmidt FI, Haniffa M, Heath JR, Kummerer BM, Keitel V, Jensen B, Stubbemann P, Kurth F, Sander LE, Sawitzki B, Deutsche C-OI, Aschenbrenner AC, Schultze JL, Nattermann J (2021) Early IFN-alpha signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity 54(2650\u20132669). https:\/\/doi.org\/10.1016\/j.immuni.2021.09.002","journal-title":"Immunity"},{"key":"1315_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd7114","author":"L Kuri-Cervantes","year":"2020","unstructured":"Kuri-Cervantes L, Pampena MB, Meng W, Rosenfeld AM, Ittner CAG, Weisman AR, Agyekum RS, Mathew D, Baxter AE, Vella LA, Kuthuru O, Apostolidis SA, Bershaw L, Dougherty J, Greenplate AR, Pattekar A, Kim J, Han N, Gouma S, Weirick ME, Arevalo CP, Bolton MJ, Goodwin EC, Anderson EM, Hensley SE, Jones TK, Mangalmurti NS, Luning Prak ET, Wherry EJ, Meyer NJ, Betts MR (2020) Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.abd7114","journal-title":"Sci Immunol"},{"key":"1315_CR55","doi-asserted-by":"publisher","DOI":"10.1101\/2021.07.11.21260338","author":"JE Lemieux","year":"2021","unstructured":"Lemieux JE, Li A, Gentili M, Perugino CA, Weiss ZF, Bowman K, Ankomah P, Liu H, Lewis GD, Bitar N, Lipiner T, Hacohen N, Pillai SS, Goldberg MB (2021) Vaccine serologic responses among transplant patients associate with COVID-19 infection and T peripheral helper cells. medRxiv. https:\/\/doi.org\/10.1101\/2021.07.11.21260338","journal-title":"medRxiv"},{"key":"1315_CR56","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"M Letko","year":"2020","unstructured":"Letko M, Marzi A, Munster V (2020) Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 5:562\u2013569. https:\/\/doi.org\/10.1038\/s41564-020-0688-y","journal-title":"Nat Microbiol"},{"issue":"Suppl 1","key":"1315_CR57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/ijlh.13500","volume":"43","author":"JH Levy","year":"2021","unstructured":"Levy JH, Iba T, Olson LB, Corey KM, Ghadimi K, Connors JM (2021) COVID-19: Thrombosis, thromboinflammation, and anticoagulation considerations. Int J Lab Hematol 43(Suppl 1):29\u201335. https:\/\/doi.org\/10.1111\/ijlh.13500","journal-title":"Int J Lab Hematol"},{"key":"1315_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117390","volume":"545","author":"B Lin","year":"2023","unstructured":"Lin B, Cheng L, Zhang J, Yang M, Zhang Y, Liu J, Qin X (2023) Immunology of SARS-CoV-2 infection and vaccination. Clin Chim Acta 545. https:\/\/doi.org\/10.1016\/j.cca.2023.117390","journal-title":"Clin Chim Acta"},{"key":"1315_CR59","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ajem.2022.01.028","volume":"54","author":"B Long","year":"2022","unstructured":"Long B, Carius BM, Chavez S, Liang SY, Brady WJ, Koyfman A, Gottlieb M (2022) Clinical update on COVID-19 for the emergency clinician: presentation and evaluation. Am J Emerg Med 54:46\u201357. https:\/\/doi.org\/10.1016\/j.ajem.2022.01.028","journal-title":"Am J Emerg Med"},{"key":"1315_CR60","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.chom.2021.05.004","volume":"29","author":"SA Lowery","year":"2021","unstructured":"Lowery SA, Sariol A, Perlman S (2021) Innate immune and inflammatory responses to SARS-CoV-2: implications for COVID-19. Cell Host Microbe 29:1052\u20131062. https:\/\/doi.org\/10.1016\/j.chom.2021.05.004","journal-title":"Cell Host Microbe"},{"key":"1315_CR61","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-00532-2","volume":"23","author":"J Majumder","year":"2021","unstructured":"Majumder J, Minko T (2021) Recent developments on therapeutic and diagnostic approaches for COVID-19. AAPS J 23. https:\/\/doi.org\/10.1208\/s12248-020-00532-2","journal-title":"AAPS J"},{"key":"1315_CR62","doi-asserted-by":"publisher","DOI":"10.1055\/a-2109-3876","author":"J McKinney","year":"2023","unstructured":"McKinney J, Salmanian B, Grace R, Moufarrij S, Sangi-Haghpeykar H, Eppes C, Gandhi M (2023) Social drivers of COVID-19 disease severity in pregnant patients. Am J Perinatol. https:\/\/doi.org\/10.1055\/a-2109-3876","journal-title":"Am J Perinatol"},{"key":"1315_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1440","volume":"13","author":"H Meng","year":"2023","unstructured":"Meng H, Sengupta A, Ricciotti E, Mrcela A, Mathew D, Mazaleuskaya LL, Ghosh S, Brooks TG, Turner AP, Schanoski AS, Lahens NF, Tan AW, Woolfork A, Grant G, Susztak K, Letizia AG, Sealfon SC, Wherry EJ, Laudanski K, Weljie AM, Meyer NJ, FitzGerald GA (2023) Deep phenotyping of the lipidomic response in COVID-19 and non-COVID-19 sepsis. Clin Transl Med 13. https:\/\/doi.org\/10.1002\/ctm2.1440","journal-title":"Clin Transl Med"},{"key":"1315_CR64","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41579-022-00839-1","volume":"21","author":"JM Minkoff","year":"2023","unstructured":"Minkoff JM, tenOever B (2023) Innate immune evasion strategies of SARS-CoV-2. Nat Rev Microbiol 21:178\u2013194. https:\/\/doi.org\/10.1038\/s41579-022-00839-1","journal-title":"Nat Rev Microbiol"},{"key":"1315_CR65","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/jmv.27487","volume":"94","author":"K Mohamed","year":"2022","unstructured":"Mohamed K, Rzymski P, Islam MS, Makuku R, Mushtaq A, Khan A, Ivanovska M, Makka SA, Hashem F, Marquez L, Cseprekal O, Filgueiras IS, Fonseca DLM, Mickael E, Ling I, Arero AG, Cuschieri S, Minakova K, Rodriguez-Roman E, Abarikwu SO, Faten AB, Grancini G, Cabral-Marques O, Rezaei N (2022) COVID-19 vaccinations: The unknowns, challenges, and hopes. J Med Virol 94:1336\u20131349. https:\/\/doi.org\/10.1002\/jmv.27487","journal-title":"J Med Virol"},{"key":"1315_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.131324","author":"S Moneshwaran","year":"2024","unstructured":"Moneshwaran S, Macrin D, Kanagathara N (2024) An unprecedented global challenge, emerging trends and innovations in the fight against COVID-19: a comprehensive review. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131324","journal-title":"Int J Biol Macromol"},{"issue":"603\u2013613","key":"1315_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.026","volume":"185","author":"Mudd PA, Minervina AA, Pogorelyy MV, Turner JS, Kim W, Kalaidina E, Petersen J, Schmitz AJ, Lei T, Haile A, Kirk AM, Mettelman RC, Crawford JC, Nguyen THO, Rowntree LC, Rosati E, Richards KA, Sant AJ, Klebert MK, Suessen T, Middleton WD, Team SS, Wolf J, Teefey SA, O\u2019Halloran JA, Presti RM, Kedzierska K, Rossjohn J, Thomas PG, Ellebedy AH","year":"2022","unstructured":"Mudd PA, Minervina AA, Pogorelyy MV, Turner JS, Kim W, Kalaidina E, Petersen J, Schmitz AJ, Lei T, Haile A, Kirk AM, Mettelman RC, Crawford JC, Nguyen THO, Rowntree LC, Rosati E, Richards KA, Sant AJ, Klebert MK, Suessen T, Middleton WD, Team SS, Wolf J, Teefey SA, O\u2019Halloran JA, Presti RM, Kedzierska K, Rossjohn J, Thomas PG, Ellebedy AH (2022) SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans. Cell 185(603\u2013613). https:\/\/doi.org\/10.1016\/j.cell.2021.12.026","journal-title":"Cell"},{"key":"1315_CR68","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143928","author":"PA Mudd","year":"2021","unstructured":"Mudd PA, Remy KE (2021) Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity? J Clin Invest. https:\/\/doi.org\/10.1172\/JCI143928","journal-title":"J Clin Invest"},{"key":"1315_CR69","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.biochi.2020.09.018","volume":"179","author":"S Muralidar","year":"2020","unstructured":"Muralidar S, Ambi SV, Sekaran S, Krishnan UM (2020) The emergence of COVID-19 as a global pandemic: understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie 179:85\u2013100. https:\/\/doi.org\/10.1016\/j.biochi.2020.09.018","journal-title":"Biochimie"},{"key":"1315_CR70","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/imr.13115","volume":"309","author":"DC Nguyen","year":"2022","unstructured":"Nguyen DC, Lamothe PA, Woodruff MC, Saini AS, Faliti CE, Sanz I, Lee FE (2022) COVID-19 and plasma cells: is there long-lived protection? Immunol Rev 309:40\u201363. https:\/\/doi.org\/10.1111\/imr.13115","journal-title":"Immunol Rev"},{"key":"1315_CR71","doi-asserted-by":"publisher","unstructured":"Nourizadeh M, Feizabadi E, Mirmoghtadaei M, Mohammadi A, Fazlollahi MR, Moradi L, Pourpak Z (2023) Antibody Production after COVID-19 Vaccination in Patients with Inborn Errors of Immunity. Iran J Immunol 20:400\u2013409. https:\/\/doi.org\/10.22034\/iji.2023.97759.2525.","DOI":"10.22034\/iji.2023.97759.2525"},{"issue":"Suppl 27","key":"1315_CR72","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/pai.13644","volume":"33","author":"GF Parisi","year":"2022","unstructured":"Parisi GF, Brindisi G, Indolfi C, Diaferio L, Marchese G, Ghiglioni DG, Zicari AM, Miraglia Del Giudice M (2022) COVID-19, anosmia, and ageusia in atopic children. Pediatr Allergy Immunol 33(Suppl 27):99\u2013101. https:\/\/doi.org\/10.1111\/pai.13644","journal-title":"Pediatr Allergy Immunol"},{"key":"1315_CR73","doi-asserted-by":"publisher","unstructured":"PD-1\/IL17A pathway. Pharmacological Research 176. https:\/\/doi.org\/10.1016\/j.phrs.2022.106083.","DOI":"10.1016\/j.phrs.2022.106083"},{"key":"1315_CR74","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Qin","year":"2020","unstructured":"Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W, Tian DS (2020) Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 71:762\u2013768. https:\/\/doi.org\/10.1093\/cid\/ciaa248","journal-title":"Clin Infect Dis"},{"key":"1315_CR75","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.immuni.2021.01.014","volume":"54","author":"I Quast","year":"2021","unstructured":"Quast I, Tarlinton D (2021) B cell memory: understanding COVID-19. Immunity 54:205\u2013210. https:\/\/doi.org\/10.1016\/j.immuni.2021.01.014","journal-title":"Immunity"},{"key":"1315_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28751","author":"MS Qudus","year":"2023","unstructured":"Qudus MS, Tian MF, Sirajuddin S, Liu SY, Afaq U, Wali M, Liu JB, Pan P, Luo Z, Zhang QW, Yang G, Wan P, Li YK, Wu JG (2023) The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.28751","journal-title":"J Med Virol"},{"key":"1315_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01446","volume":"11","author":"D Ragab","year":"2020","unstructured":"Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R (2020) The COVID-19 cytokine storm; what we know so far. Front Immunol 11. https:\/\/doi.org\/10.3389\/fimmu.2020.01446","journal-title":"Front Immunol"},{"key":"1315_CR78","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00299-20","author":"S Ramasamy","year":"2021","unstructured":"Ramasamy S, Subbian S (2021) Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis. Clin Microbiol Rev. https:\/\/doi.org\/10.1128\/CMR.00299-20","journal-title":"Clin Microbiol Rev"},{"issue":"1895\u20131913","key":"1315_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.053","volume":"184","author":"X Ren","year":"2021","unstructured":"Ren X, Wen W, Fan X, Hou W, Su B, Cai P, Li J, Liu Y, Tang F, Zhang F, Yang Y, He J, Ma W, He J, Wang P, Cao Q, Chen F, Chen Y, Cheng X, Deng G, Deng X, Ding W, Feng Y, Gan R, Guo C, Guo W, He S, Jiang C, Liang J, Li YM, Lin J, Ling Y, Liu H, Liu J, Liu N, Liu SQ, Luo M, Ma Q, Song Q, Sun W, Wang G, Wang F, Wang Y, Wen X, Wu Q, Xu G, Xie X, Xiong X, Xing X, Xu H, Yin C, Yu D, Yu K, Yuan J, Zhang B, Zhang P, Zhang T, Zhao J, Zhao P, Zhou J, Zhou W, Zhong S, Zhong X, Zhang S, Zhu L, Zhu P, Zou B, Zou J, Zuo Z, Bai F, Huang X, Zhou P, Jiang Q, Huang Z, Bei JX, Wei L, Bian XW, Liu X, Cheng T, Li X, Zhao P, Wang FS, Wang H, Su B, Zhang Z, Qu K, Wang X, Chen J, Jin R, Zhang Z (2021) COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell 184(1895\u20131913). https:\/\/doi.org\/10.1016\/j.cell.2021.01.053","journal-title":"Cell"},{"key":"1315_CR80","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser EC, Mauri C (2015) Regulatory B cells: origin, phenotype, and function. Immunity 42:607\u2013612. https:\/\/doi.org\/10.1016\/j.immuni.2015.04.005","journal-title":"Immunity"},{"key":"1315_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.611337","author":"MW Russell","year":"2020","unstructured":"Russell MW, Moldoveanu Z, Ogra PL, Mestecky J (2020) Mucosal immunity in COVID-19: a neglected but critical aspect of SARS-CoV-2 infection. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.611337","journal-title":"Front Immunol"},{"key":"1315_CR82","doi-asserted-by":"publisher","first-page":"17344","DOI":"10.1038\/s41598-023-43675-w","volume":"13","author":"F Saheb Sharif-Askari","year":"2023","unstructured":"Saheb Sharif-Askari F, Saheb Sharif-Askari N, Hafezi S, Alsayed HAH, Selvakumar B, Eladham MWA, Mdkhana B, Bayram OS, Temsah MH, Halwani R (2023) Increased blood immune regulatory cells in severe COVID-19 with autoantibodies to type I interferons. Sci Rep 13:17344. https:\/\/doi.org\/10.1038\/s41598-023-43675-w","journal-title":"Sci Rep"},{"key":"1315_CR83","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejim.2022.06.001","volume":"102","author":"M Samson","year":"2022","unstructured":"Samson M, Nicolas B, Ciudad M, Greigert H, Guilhem A, Cladiere C, Straub C, Blot M, Piroth L, Rogier T, Devilliers H, Manckoundia P, Ghesquiere T, Francois S, Lakomy D, Audia S, Bonnotte B (2022) T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients. Eur J Intern Med 102:104\u2013109. https:\/\/doi.org\/10.1016\/j.ejim.2022.06.001","journal-title":"Eur J Intern Med"},{"key":"1315_CR84","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/s41467-023-37368-1","volume":"14","author":"A Santa Cruz","year":"2023","unstructured":"Santa Cruz A, Mendes-Frias A, Azarias-da-Silva M, Andre S, Oliveira AI, Pires O, Mendes M, Oliveira B, Braga M, Lopes JR, Domingues R, Costa R, Silva LN, Matos AR, Angela C, Costa P, Carvalho A, Capela C, Pedrosa J, Castro AG, Estaquier J, Silvestre R (2023) Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8(+)beta7 integrin(+) T cells and anti-SARS-CoV-2 IgA response. Nat Commun 14:1772. https:\/\/doi.org\/10.1038\/s41467-023-37368-1","journal-title":"Nat Commun"},{"key":"1315_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10122055","author":"A Sarantaki","year":"2022","unstructured":"Sarantaki A, Kalogeropoulou VE, Taskou C, Nanou C, Lykeridou A (2022) COVID-19 vaccination and related determinants of hesitancy among pregnant women: a systematic review and meta-analysis. Vaccines. https:\/\/doi.org\/10.3390\/vaccines10122055","journal-title":"Vaccines"},{"key":"1315_CR86","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.2174\/1389557520666200807131855","volume":"20","author":"K Sarkar","year":"2020","unstructured":"Sarkar K, Sil PC, Nabavi SF, Berindan-Neagoe I, Cismaru CA, Nabavi SM, Habtemariam S (2020) Possible targets and therapies of SARS-CoV-2 infection. Mini Rev Med Chem 20:1900\u20131907. https:\/\/doi.org\/10.2174\/1389557520666200807131855","journal-title":"Mini Rev Med Chem"},{"key":"1315_CR87","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01532-22","volume":"97","author":"C Schindewolf","year":"2023","unstructured":"Schindewolf C, Lokugamage K, Vu MN, Johnson BA, Scharton D, Plante JA, Kalveram B, Crocquet-Valdes PA, Sotcheff S, Jaworski E, Alvarado RE, Debbink K, Daugherty MD, Weaver SC, Routh AL, Walker DH, Plante KS, Menachery VD (2023) SARS-CoV-2 uses nonstructural protein 16 to evade restriction by IFIT1 and IFIT3. J Virol 97. https:\/\/doi.org\/10.1128\/jvi.01532-22","journal-title":"J Virol"},{"key":"1315_CR88","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-022-04802-1","volume":"606","author":"E Sefik","year":"2022","unstructured":"Sefik E, Qu R, Junqueira C, Kaffe E, Mirza H, Zhao J, Brewer JR, Han A, Steach HR, Israelow B, Blackburn HN, Velazquez SE, Chen YG, Halene S, Iwasaki A, Meffre E, Nussenzweig M, Lieberman J, Wilen CB, Kluger Y, Flavell RA (2022) Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature 606:585\u2013593. https:\/\/doi.org\/10.1038\/s41586-022-04802-1","journal-title":"Nature"},{"key":"1315_CR89","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1377\/hlthaff.2020.00897","volume":"39","author":"TM Selden","year":"2020","unstructured":"Selden TM, Berdahl TA (2020) COVID-19 and racial\/ethnic disparities in health risk, employment, and household composition. Health Aff (Millwood) 39:1624\u20131632. https:\/\/doi.org\/10.1377\/hlthaff.2020.00897","journal-title":"Health Aff (Millwood)"},{"key":"1315_CR90","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.15585\/mmwr.mm7239a2","volume":"72","author":"HM Shephard","year":"2023","unstructured":"Shephard HM, Manning SE, Nestoridi E, Darling AM, Brown CM, Hatch M, Ahnger-Pier K, Pagnano S, Mather D, Yazdy MM (2023) Inequities in COVID-19 vaccination coverage among pregnant persons, by disaggregated race and ethnicity - Massachusetts, May 2021-October 2022. MMWR Morb Mortal Wkly Rep 72:1052\u20131056. https:\/\/doi.org\/10.15585\/mmwr.mm7239a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1315_CR91","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2980","volume":"370","author":"RA Siemieniuk","year":"2020","unstructured":"Siemieniuk RA, Bartoszko JJ, Zeraatkar D, Kum E, Qasim A, Martinez JPD, Izcovich A, Lamontagne F, Han MA, Agarwal A, Agoritsas T, Azab M, Bravo G, Chu DK, Couban R, Devji T, Escamilla Z, Foroutan F, Gao Y, Ge L, Ghadimi M, Heels-Ansdell D, Honarmand K, Hou L, Ibrahim Q, Khamis A, Lam B, Mansilla C, Loeb M, Miroshnychenko A, Marcucci M, McLeod SL, Motaghi S, Murthy S, Mustafa RA, Pardo-Hernandez H, Rada G, Rizwan Y, Saadat P, Switzer C, Thabane L, Tomlinson G, Vandvik PO, Vernooij RW, Viteri-Garcia A, Wang Y, Yao L, Zhao Y, Guyatt GH, Brignardello-Petersen R (2020) Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ 370. https:\/\/doi.org\/10.1136\/bmj.m2980","journal-title":"BMJ"},{"key":"1315_CR92","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s10456-021-09805-6","volume":"24","author":"DM Smadja","year":"2021","unstructured":"Smadja DM, Mentzer SJ, Fontenay M, Laffan MA, Ackermann M, Helms J, Jonigk D, Chocron R, Pier GB, Gendron N, Pons S, Diehl JL, Margadant C, Guerin C, Huijbers EJM, Philippe A, Chapuis N, Nowak-Sliwinska P, Karagiannidis C, Sanchez O, Kumpers P, Skurnik D, Randi AM, Griffioen AW (2021) COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis 24:755\u2013788. https:\/\/doi.org\/10.1007\/s10456-021-09805-6","journal-title":"Angiogenesis"},{"key":"1315_CR93","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2217902120","volume":"120","author":"JN Sondergaard","year":"2023","unstructured":"Sondergaard JN, Tulyeu J, Edahiro R, Shirai Y, Yamaguchi Y, Murakami T, Morita T, Kato Y, Hirata H, Takeda Y, Okuzaki D, Sakaguchi S, Kumanogoh A, Okada Y, Wing JB (2023) A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients. Proc Natl Acad Sci U S A 120. https:\/\/doi.org\/10.1073\/pnas.2217902120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1315_CR94","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"27","author":"Stephenson E, Reynolds G, Botting RA, Calero-Nieto FJ, Morgan MD, Tuong ZK, Bach K, Sungnak W, Worlock KB, Yoshida M, Kumasaka N, Kania K, Engelbert J, Olabi B, Spegarova JS, Wilson NK, Mende N, Jardine L, Gardner LCS, Goh I, Horsfall D, McGrath J, Webb S, Mather MW, Lindeboom RGH, Dann E, Huang N, Polanski K, Prigmore E, Gothe F, Scott J, Payne RP, Baker KF, Hanrath AT, Schim van der Loeff ICD, Barr AS, Sanchez-Gonzalez A, Bergamaschi L, Mescia F, Barnes JL, Kilich E, de Wilton A, Saigal A, Saleh A, Janes SM, Smith CM, Gopee N, Wilson C, Coupland P, Coxhead JM, Kiselev VY, van Dongen S, Bacardit J, King HW, Cambridge Institute of Therapeutic I, Infectious Disease-National Institute of Health Research C-BC, Rostron AJ, Simpson AJ, Hambleton S, Laurenti E, Lyons PA, Meyer KB, Nikolic MZ, Duncan CJA, Smith KGC, Teichmann SA, Clatworthy MR, Marioni JC, Gottgens B, Haniffa M","year":"2021","unstructured":"Stephenson E, Reynolds G, Botting RA, Calero-Nieto FJ, Morgan MD, Tuong ZK, Bach K, Sungnak W, Worlock KB, Yoshida M, Kumasaka N, Kania K, Engelbert J, Olabi B, Spegarova JS, Wilson NK, Mende N, Jardine L, Gardner LCS, Goh I, Horsfall D, McGrath J, Webb S, Mather MW, Lindeboom RGH, Dann E, Huang N, Polanski K, Prigmore E, Gothe F, Scott J, Payne RP, Baker KF, Hanrath AT, Schim van der Loeff ICD, Barr AS, Sanchez-Gonzalez A, Bergamaschi L, Mescia F, Barnes JL, Kilich E, de Wilton A, Saigal A, Saleh A, Janes SM, Smith CM, Gopee N, Wilson C, Coupland P, Coxhead JM, Kiselev VY, van Dongen S, Bacardit J, King HW, Cambridge Institute of Therapeutic I, Infectious Disease-National Institute of Health Research C-BC, Rostron AJ, Simpson AJ, Hambleton S, Laurenti E, Lyons PA, Meyer KB, Nikolic MZ, Duncan CJA, Smith KGC, Teichmann SA, Clatworthy MR, Marioni JC, Gottgens B, Haniffa M (2021) Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med 27:904\u2013916. https:\/\/doi.org\/10.1038\/s41591-021-01329-2","journal-title":"Nat Med"},{"key":"1315_CR95","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01853-2023","author":"CH Sudre","year":"2024","unstructured":"Sudre CH, Antonelli M, Cheetham NJ, Molteni E, Canas LS, Bowyer V, Murray B, Rjoob K, Modat M, Capdevila Pujol J, Hu C, Wolf J, Spector TD, Hammers A, Steves CJ, Ourselin S, Duncan EL (2024) Symptoms before and after COVID-19: a population and case-control study using prospective data. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.01853-2023","journal-title":"Eur Respir J"},{"key":"1315_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286142","volume":"18","author":"M Summanen","year":"2023","unstructured":"Summanen M, Kosunen M, Kainu V, Cansel A, Niskanen S, Nurmi L, Leskela RL, Isomeri O (2023) COVID-19 hospitalisations and all-cause mortality by risk group in Finland. PLoS One 18. https:\/\/doi.org\/10.1371\/journal.pone.0286142","journal-title":"PLoS One"},{"key":"1315_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.580641","volume":"11","author":"N Taefehshokr","year":"2020","unstructured":"Taefehshokr N, Taefehshokr S, Hemmat N, Heit B (2020) Covid-19: perspectives on innate immune evasion. Front Immunol 11. https:\/\/doi.org\/10.3389\/fimmu.2020.580641","journal-title":"Front Immunol"},{"key":"1315_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30310-6","volume":"2","author":"R The Lancet","year":"2020","unstructured":"The Lancet R (2020) High-stakes heterogeneity in COVID-19. Lancet Rheumatol 2. https:\/\/doi.org\/10.1016\/S2665-9913(20)30310-6","journal-title":"Lancet Rheumatol"},{"key":"1315_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113201","volume":"213","author":"L Tian","year":"2021","unstructured":"Tian L, Qiang T, Liang C, Ren X, Jia M, Zhang J, Li J, Wan M, YuWen X, Li H, Cao W, Liu H (2021) RNA-dependent RNA polymerase (RdRp) inhibitors: the current landscape and repurposing for the COVID-19 pandemic. Eur J Med Chem 213. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113201","journal-title":"Eur J Med Chem"},{"key":"1315_CR100","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1182\/blood.2021012248","volume":"140","author":"AAR Tobian","year":"2022","unstructured":"Tobian AAR, Cohn CS, Shaz BH (2022) COVID-19 convalescent plasma. Blood 140:196\u2013207. https:\/\/doi.org\/10.1182\/blood.2021012248","journal-title":"Blood"},{"key":"1315_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176351","author":"C van Eeden","year":"2020","unstructured":"van Eeden C, Khan L, Osman MS, Tervaert JWC (2020) Natural killer cell dysfunction and its role in COVID-19. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21176351","journal-title":"Int J Mol Sci"},{"key":"1315_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.152008","volume":"225","author":"PM Varghese","year":"2020","unstructured":"Varghese PM, Tsolaki AG, Yasmin H, Shastri A, Ferluga J, Vatish M, Madan T, Kishore U (2020) Host-pathogen interaction in COVID-19: pathogenesis, potential therapeutics and vaccination strategies. Immunobiology 225. https:\/\/doi.org\/10.1016\/j.imbio.2020.152008","journal-title":"Immunobiology"},{"key":"1315_CR103","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00796-2023","author":"VC Veiga","year":"2023","unstructured":"Veiga VC, Cavalcanti AB (2023) Age, host response, and mortality in COVID-19. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.00796-2023","journal-title":"Eur Respir J"},{"key":"1315_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1066456","author":"T Wallach","year":"2023","unstructured":"Wallach T, Raden M, Hinkelmann L, Brehm M, Rabsch D, Weidling H, Kr\u00fcger C, Kettenmann H, Backofen R, Lehnardt S (2023) Distinct SARS-CoV-2 RNA fragments activate Toll-like receptors 7 and 8 and induce cytokine release from human macrophages and microglia. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.1066456","journal-title":"Front Immunol"},{"key":"1315_CR105","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.14336\/AD.2021.0709","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang H, Wang Z, Cao W, Wu Q, Yuan Y, Zhang X (2021) Regulatory T cells in COVID-19. Aging Dis 12:1545\u20131553. https:\/\/doi.org\/10.14336\/AD.2021.0709","journal-title":"Aging Dis"},{"key":"1315_CR106","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1080\/14787210.2022.2078307","volume":"20","author":"Q Wang","year":"2022","unstructured":"Wang Q, Wu X, Mao Q, Gao F, Liu M, Song Z, Bian L, Liang Z (2022) How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review. Expert Rev Anti-infect Ther 20:1119\u20131127. https:\/\/doi.org\/10.1080\/14787210.2022.2078307","journal-title":"Expert Rev Anti-infect Ther"},{"key":"1315_CR107","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11538-022-01058-8","volume":"84","author":"X Wang","year":"2022","unstructured":"Wang X, Wang S, Wang J, Rong L (2022) A multiscale model of COVID-19 dynamics. Bull Math Biol 84:99. https:\/\/doi.org\/10.1007\/s11538-022-01058-8","journal-title":"Bull Math Biol"},{"key":"1315_CR108","doi-asserted-by":"crossref","unstructured":"Wang YY, Wang X, Li YX, Xue ZF, Shao R, Li L, Zhu Y, Zhang H, Yang J (2022c) Xuanfei Baidu Decoction reduces acute lung injury by regulating infiltration of neutrophils and macrophages","DOI":"10.1016\/j.phrs.2022.106083"},{"key":"1315_CR109","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jval.2021.12.008","volume":"25","author":"B Wouterse","year":"2022","unstructured":"Wouterse B, Ram F, van Baal P (2022) Quality-adjusted life-years lost due to COVID-19 mortality: methods and application for the Netherlands. Value Health 25:731\u2013735. https:\/\/doi.org\/10.1016\/j.jval.2021.12.008","journal-title":"Value Health"},{"key":"1315_CR110","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/med.21776","volume":"41","author":"Y Wu","year":"2021","unstructured":"Wu Y, Li Z, Zhao YS, Huang YY, Jiang MY, Luo HB (2021) Therapeutic targets and potential agents for the treatment of COVID-19. Med Res Rev 41:1775\u20131797. https:\/\/doi.org\/10.1002\/med.21776","journal-title":"Med Res Rev"},{"key":"1315_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108761","volume":"34","author":"J Wu","year":"2021","unstructured":"Wu J, Shi Y, Pan X, Wu S, Hou R, Zhang Y, Zhong T, Tang H, Du W, Wang L, Wo J, Mu J, Qiu Y, Yang K, Zhang LK, Ye BC, Qi N (2021) SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO. Cell Rep 34. https:\/\/doi.org\/10.1016\/j.celrep.2021.108761","journal-title":"Cell Rep"},{"key":"1315_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108234","volume":"33","author":"H Xia","year":"2020","unstructured":"Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi PY (2020) Evasion of type I interferon by SARS-CoV-2. Cell Rep 33. https:\/\/doi.org\/10.1016\/j.celrep.2020.108234","journal-title":"Cell Rep"},{"key":"1315_CR113","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/jmv.27542","volume":"94","author":"HR Xiang","year":"2022","unstructured":"Xiang HR, He B, Li Y, Cheng X, Zhang QZ, Peng WX (2022) Bamlanivimab plus etesevimab treatment have a better outcome against COVID-19: a meta-analysis. J Med Virol 94:1893\u20131905. https:\/\/doi.org\/10.1002\/jmv.27542","journal-title":"J Med Virol"},{"key":"1315_CR114","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","volume":"63","author":"X Xu","year":"2020","unstructured":"Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, Zhong W, Hao P (2020) Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 63:457\u2013460. https:\/\/doi.org\/10.1007\/s11427-020-1637-5","journal-title":"Sci China Life Sci"},{"key":"1315_CR115","doi-asserted-by":"publisher","unstructured":"Ye H, Liu ZM, Zhou L, Li F, Cai Q, Zhang MF, Mu QS (2023) Levels of peripheral IL-6 and CD4+ and CD8+ T cells and their prognostic significance in COVID-19. Eur Rev Med Pharmacol Sci 27:2686\u20132691. https:\/\/doi.org\/10.26355\/eurrev_202303_31806.","DOI":"10.26355\/eurrev_202303_31806"},{"key":"1315_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37835-9","volume":"14","author":"M Yu","year":"2023","unstructured":"Yu M, Charles A, Cagigi A, Christ W, Osterberg B, Falck-Jones S, Azizmohammadi L, Ahlberg E, Falck-Jones R, Svensson J, Nie M, Warnqvist A, Hellgren F, Lenart K, Arcoverde Cerveira R, Ols S, Lindgren G, Lin A, Maecker H, Bell M, Johansson N, Albert J, Sundling C, Czarnewski P, Klingstrom J, Farnert A, Lore K, Smed-Sorensen A (2023) Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19. Nat Commun 14. https:\/\/doi.org\/10.1038\/s41467-023-37835-9","journal-title":"Nat Commun"},{"key":"1315_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1125246","volume":"14","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, Jiao B, Qu L, Yang D, Liu R (2023) The development of COVID-19 treatment. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1125246","journal-title":"Front Immunol"},{"key":"1315_CR118","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/21505594.2022.2047506","volume":"13","author":"AM Zahran","year":"2022","unstructured":"Zahran AM, Abdel-Rahim MH, Nasif KA, Hussein S, Hafez R, Ahmad AB, Saad K, Elhoufey A, Hussein HAM, Thabet AA, El-Badawy O (2022) Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients. Virulence 13:569\u2013577. https:\/\/doi.org\/10.1080\/21505594.2022.2047506","journal-title":"Virulence"},{"key":"1315_CR119","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.21037\/apm-20-753","volume":"9","author":"L Zha","year":"2020","unstructured":"Zha L, Xu X, Wang D, Qiao G, Zhuang W, Huang S (2020) Modified rehabilitation exercises for mild cases of COVID-19. Ann Palliat Med 9:3100\u20133106. https:\/\/doi.org\/10.21037\/apm-20-753","journal-title":"Ann Palliat Med"},{"issue":"2434\u20132451","key":"1315_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.05.022","volume":"185","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Mateus J, Coelho CH, Dan JM, Moderbacher CR, Galvez RI, Cortes FH, Grifoni A, Tarke A, Chang J, Escarrega EA, Kim C, Goodwin B, Bloom NI, Frazier A, Weiskopf D, Sette A, Crotty S (2022) Humoral and cellular immune memory to four COVID-19 vaccines. Cell 185(2434\u20132451). https:\/\/doi.org\/10.1016\/j.cell.2022.05.022","journal-title":"Cell"},{"key":"1315_CR121","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2184754","volume":"19","author":"X Zhou","year":"2023","unstructured":"Zhou X, Lu H, Sang M, Qiu S, Yuan Y, Wu T, Chen J, Sun Z (2023) Impaired antibody response to inactivated COVID-19 vaccines in hospitalized patients with type 2 diabetes. Hum Vaccin Immunother 19. https:\/\/doi.org\/10.1080\/21645515.2023.2184754","journal-title":"Hum Vaccin Immunother"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01315-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-025-01315-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01315-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T17:03:59Z","timestamp":1758992639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-025-01315-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1315"],"URL":"https:\/\/doi.org\/10.1007\/s12223-025-01315-y","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}